The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Population-wide Impact of Long-term Use of Aspirin and the Risk for Cancer
Open accessAbstract
IMPORTANCE: The US Preventive Services Task Force recently recommended the use of aspirin to prevent colorectal cancer and cardiovascular disease among many US adults. However, the association of aspirin use with the risk for other cancer types and the potential population-wide effect of aspirin use on cancer, particularly within the context of screening, remain uncertain. OBJECTIVES: To examine the potential benefits of aspirin use for overall and subtype-specific cancer prevention at a range of doses and durations of use and to estimate the absolute benefit of aspirin in the context of screening. DESIGN, SETTING, AND PARTICIPANTS: Two large US prospective cohort studies, the Nurses' Health Study (1980-2010) and Health Professionals Follow-up Study (1986-2012), followed up 135 965 health care professionals (88 084 women and 47 881 men, respectively) who reported on aspirin use biennially. The women were aged 30 to 55 years at enrollment in 1976; the men, aged 40 to 75 years in 1986. Final follow-up was completed on June 30, 2012, for the Nurses' Health Study cohort and January 31, 2010, for the Health Professionals Follow-up Study cohort, and data were accessed from September 15, 2014, to December 17, 2015. MAIN OUTCOMES AND MEASURES: Relative risks (RRs) for incident cancers and population-attributable risk (PAR). RESULTS: Among the 88 084 women and 47 881 men who underwent follow-up for as long as 32 years, 20 414 cancers among women and 7571 cancers among men were documented. Compared with nonregular use, regular aspirin use was associated with a lower risk for overall cancer (RR, 0.97; 95% CI, 0.94-0.99), which was primarily owing to a lower incidence of gastrointestinal tract cancers (RR, 0.85; 95% CI, 0.80-0.91), especially colorectal cancers (RR, 0.81; 95% CI, 0.75-0.88). The benefit of aspirin on gastrointestinal tract cancers appeared evident with the use of at least 0.5 to 1.5 standard aspirin tablets per week; the minimum duration of regular use associated with a lower risk was 6 years. Among individuals older than 50 years, regular aspirin use could prevent 33 colorectal cancers per 100 000 person-years (PAR, 17.0%) among those who had not undergone a lower endoscopy and 18 colorectal cancers per 100 000 person-years (PAR, 8.5%) among those who had. Regular aspirin use was not associated with the risk for breast, advanced prostate, or lung cancer. CONCLUSIONS AND RELEVANCE: Long-term aspirin use was associated with a modest but significantly reduced risk for overall cancer, especially gastrointestinal tract tumors. Regular aspirin use may prevent a substantial proportion of colorectal cancers and complement the benefits of screening.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Edwards, B. K., Ward, E., Kohler, B. A., Eheman, C., Zauber, A. G., Anderson, R. N., Jemal, A., Schymura, M. J., Lansdorp‐Vogelaar, I., Seeff, L. C., et al. (2010) · Cancer · doi:10.1002/cncr.24760 · Cited by 2,002
Alternative Dietary Indices Both Strongly Predict Risk of Chronic Disease
Chiuve, S. E., Fung, T. T., Rimm, E. B., Hu, F. B., McCullough, M. L., Wang, M., Stampfer, M. J., & Willett, W. C. (2012) · The Journal of Nutrition · doi:10.3945/jn.111.157222 · Cited by 1,951
Self-citationContribution of platelets to tumour metastasis
Gay, L. J., & Felding-Habermann, B. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3004 · Cited by 1,645
Rothwell, P. M., Fowkes, F. G. R., Belch, J. F., Ogawa, H., Warlow, C. P., & Meade, T. W. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62110-1 · Cited by 1,497
Long-term colorectal-cancer incidence and mortality after lower endoscopy
Nishihara, R., Wu, K., Lochhead, P., Morikawa, T., Liao, X., Qian, Z. R., Inamura, K., Kim, S. A., Kuchiba, A., Yamauchi, M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301969 · Cited by 1,483
Self-citationRothwell, P. M., Wilson, M., Elwin, C.-E., Norrving, B., Algra, A., Warlow, C. P., & Meade, T. W. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61543-7 · Cited by 1,351
The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results.
Farrell, B., Godwin, J., Richards, S., & Warlow, C. (1991) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.54.12.1044 · Cited by 1,203
McCullough, M. L., Feskanich, D., Stampfer, M. J., Giovannucci, E. L., Rimm, E. B., Hu, F. B., Spiegelman, D., Hunter, D. J., Colditz, G. A., & Willett, W. C. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.6.1261 · Cited by 1,191
Self-citationRothwell, P. M., Wilson, M., Price, J. F., Belch, J. F., Meade, T. W., & Mehta, Z. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60209-8 · Cited by 984
Rothwell, P. M., Price, J. F., Fowkes, F. G. R., Zanchetti, A., Roncaglioni, M. C., Tognoni, G., Lee, R., Belch, J. F., Wilson, M., Mehta, Z., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61720-0 · Cited by 839
Algra, A. M., & Rothwell, P. M. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70112-2 · Cited by 831
TEST OF THE NATIONAL DEATH INDEX
STAMPFER, M. J., WILLETT, W. C., SPEIZER, F. E., DYSERT, D. C., LIPNICK, R., ROSNER, B., & HENNEKENS, C. H. (1984) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113804 · Cited by 790
Self-citationAspirin Use and the Risk for Colorectal Cancer and Adenoma in Male Health Professionals
Giovannucci, E., Rimm, E. B., Stampfer, M. J., Colditz, G. A., Ascherio, A., & Willett, W. C. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-4-199408150-00001 · Cited by 785
Self-citationAspirin and the Risk of Colorectal Cancer in Relation to the Expression of COX-2
Chan, A. T., Ogino, S., & Fuchs, C. S. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067208 · Cited by 781
Self-citationAspirin Use and Survival After Diagnosis of Colorectal Cancer
Chan, A. T. (2009) · JAMA · doi:10.1001/jama.2009.1112 · Cited by 557
Self-citationTest of the National Death Index and Equifax Nationwide Death Search
Rich-Edwards, J. W., Corsano, K. A., & Stampfer, M. J. (1994) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117191 · Cited by 530
The role of aspirin in cancer prevention
Thun, M. J., Jacobs, E. J., & Patrono, C. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.199 · Cited by 481
Long-term Use of Aspirin and Nonsteroidal Anti-inflammatory Drugs and Risk of Colorectal Cancer
Chan, A. T. (2005) · JAMA · doi:10.1001/jama.294.8.914 · Cited by 478
Self-citationAspirin and colorectal cancer: the promise of precision chemoprevention
Drew, D. A., Cao, Y., & Chan, A. T. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.4 · Cited by 453
Self-citationEstimates of benefits and harms of prophylactic use of aspirin in the general population
Cuzick, J., Thorat, M. A., Bosetti, C., Brown, P. H., Burn, J., Cook, N. R., Ford, L. G., Jacobs, E. J., Jankowski, J. A., La Vecchia, C., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdu225 · Cited by 382
Aspirin Intake and Survival After Breast Cancer
Holmes, M. D., Chen, W. Y., Li, L., Hertzmark, E., Spiegelman, D., & Hankinson, S. E. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.7918 · Cited by 365
Self-citationA Large Cohort Study of Long-Term Daily Use of Adult-Strength Aspirin and Cancer Incidence
Jacobs, E. J., Thun, M. J., Bain, E. B., Rodriguez, C., Henley, S. J., & Calle, E. E. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk132 · Cited by 322
Cook, N. R., Lee, I.-M., Zhang, S. M., Moorthy, M. V., & Buring, J. E. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-2-201307160-00002 · Cited by 315
Aspirin and cancer risk: a quantitative review to 2011
Bosetti, C., Rosato, V., Gallus, S., Cuzick, J., & La Vecchia, C. (2012) · Annals of Oncology · doi:10.1093/annonc/mds113 · Cited by 297
Aspirin in the Chemoprevention of Colorectal Neoplasia: An Overview
Chan, A. T., Arber, N., Burn, J., Chia, W. K., Elwood, P., Hull, M. A., Logan, R. F., Rothwell, P. M., Schrör, K., & Baron, J. A. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0391 · Cited by 276
Self-citationA Prospective Study of Aspirin Use and Primary Prevention of Cardiovascular Disease in Women
Manson, J. E. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470040085027 · Cited by 272
Aspirin Dose and Duration of Use and Risk of Colorectal Cancer in Men
Chan, A. T., Giovannucci, E. L., Meyerhardt, J. A., Schernhammer, E. S., Wu, K., & Fuchs, C. S. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.09.035 · Cited by 242
Self-citationSutcliffe, P., Connock, M., Shyangdan, D., Court, R., Kandala, N.-B., & Clarke, A. (2013) · Health Technol Assess · doi:10.3310/hta17420 · Cited by 217
Association of Aspirin and NSAID Use With Risk of Colorectal Cancer According to Genetic Variants
Nan, H., Hutter, C. M., Lin, Y., Jacobs, E. J., Ulrich, C. M., White, E., Baron, J. A., Berndt, S. I., Brenner, H., Butterbach, K., et al. (2015) · JAMA · doi:10.1001/jama.2015.1815 · Cited by 204
Self-citationAbnet, C. C., Freedman, N. D., Kamangar, F., Leitzmann, M. F., Hollenbeck, A. R., & Schatzkin, A. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604880 · Cited by 181
Wilson, K. M., Kasperzyk, J. L., Rider, J. R., Kenfield, S. A., van Dam, R. M., Stampfer, M. J., Giovannucci, E. L., & Mucci, L. A. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr151 · Cited by 176
Self-citationAspirin Use and Risk of Colorectal Cancer According to BRAF Mutation Status
Nishihara, R., Lochhead, P., Kuchiba, A., Jung, S., Yamauchi, M., Liao, X., Imamura, Y., Qian, Z. R., Morikawa, T., Wang, M., et al. (2013) · JAMA · doi:10.1001/jama.2013.6599 · Cited by 166
Self-citationNon-Steroidal Anti-Inflammatory Drugs and Colorectal Cancer Risk in a Large, Prospective Cohort
Ruder, E. H., Laiyemo, A. O., Graubard, B. I., Hollenbeck, A. R., Schatzkin, A. G., & Cross, A. J. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.38 · Cited by 154
U.S. Preventive Services Task Force* (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-5-200703060-00008 · Cited by 140
Poston, D. L., & Bouvier, L. F. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511781001.010 · Cited by 140
Sutcliffe, P. A., Connock, M. J., Gurung, T., Freeman, K., Johnson, S. A., Kandala, N., Grove, A., Gurung, B., Morrow, S., & Clarke, A. (2013) · Health Technology Assessment · doi:10.3310/hta17430 · Cited by 111
Gala, M. K., & Chan, A. T. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0877 · Cited by 85
Self-citationZhang, X., Smith‐Warner, S. A., Collins, L. C., ROSNER, B. A., Willett, W. C., & Hankinson, S. E. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.2006 · Cited by 72
Self-citationAspirin Use and the Risk of Gastric Cancer: A Meta-Analysis
Yang, P., Zhou, Y., Chen, B., Wan, H.-W., Jia, G., Bai, H.-L., & Wu, X. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-0915-0 · Cited by 68
Where Do We Stand With Aspirin for the Prevention of Colorectal Cancer? The USPSTF Recommendations
Chan, A. T., & Ladabaum, U. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.11.018 · Cited by 45
Self-citationYe, X., Wang, J., Shi, W.-T., & He, J. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.481 · Cited by 41
Aspirin Use after a Prostate Cancer Diagnosis and Cancer Survival in a Prospective Cohort
Dhillon, P. K., Kenfield, S. A., Stampfer, M. J., Giovannucci, E. L., & Chan, J. M. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0171 · Cited by 40
Self-citationWhitlock, E., Williams, S. B., Bu, B., Feightner, A., & Beil, T. L. (2015) · Europe PMC (PubMed Central) · Cited by 35
Aspirin and lung cancer risk in a cohort study of women: dosage, duration and latency
Feskanich, D., Bain, C., Chan, A. T., Pandeya, N., Speizer, F. E., & Colditz, G. A. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603996 · Cited by 32
Self-citation
Cited by
Global Burden of Disease Cancer Collaboration, Fitzmaurice, C., Allen, C., Barber, R. M., Barregard, L., Bhutta, Z. A., Brenner, H., Dicker, D. J., Chimed-Orchir, O., Dandona, R., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.5688 · Cited by 6,215
Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies
Keum, N., & Giovannucci, E. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0189-8 · Cited by 2,661
Self-citationHandbook of Religion and Health
Koenig, H. G., VanderWeele, T., & Peteet, J. R. (2024) · doi:10.1093/oso/9780190088859.001.0001 · Cited by 1,139
Smyth, E. C., Lagergren, J., Fitzgerald, R. C., Lordick, F., Shah, M. A., Lagergren, P., & Cunningham, D. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.48 · Cited by 1,012
Hossain, M. S., Karuniawati, H., Jairoun, A. A., Urbi, Z., Ooi, D. J., John, A., Lim, Y. C., Kibria, K. M. K., Mohiuddin, A. K. M., Ming, L. C., et al. (2022) · Cancers · doi:10.3390/cancers14071732 · Cited by 920
“Equally, it has been established that the risk of CRC can be reduced by physical activity [75], regular aspirin consumption [76,77], and hormone replacement therapy [78], while certain studies have also found that consumption of milk and whole grains may help protect against CRC [74].”
Background
Metadata
- Authors
- Cao, Y., Nishihara, R., Wu, K., Wang, M., Ogino, S., Willett, W. C., Spiegelman, D., Fuchs, C. S., Giovannucci, E. L., & Chan, A. T.
- Venue
- JAMA Oncology
- Publisher
- American Medical Association (AMA)
- Published
- 2016-06-01
- Volume
- 2
- Issue
- 6
- Pages
- 762
- ISSN
- 2374-2437 (ISSN-L)
- OpenAlex
- W2290813370
- Cited by
- 369
- References
- 44
- FWCI
- 37.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.